Steven C. Quay
President & CEO at Atossa Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Atossa Therapeutics Inc., 3 years.
Atossa Therapeutics Inc.
Director · President & CEO
Chief executive roles
Atossa Therapeutics Inc.
· President & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 27, 2026 | Atossa Therapeutics Inc. | Grant or award | +65,000 | — | — |
| Jan 20, 2026 | Atossa Therapeutics Inc. | Grant or award | +325,203 | — | — |
| May 21, 2025 | Atossa Therapeutics Inc. | Open-market purchase | +11,239 | $0.88 | $9,890 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.